000 | 00960 a2200253 4500 | ||
---|---|---|---|
005 | 20250515022733.0 | ||
264 | 0 | _c20060525 | |
008 | 200605s 0 0 eng d | ||
022 | _a0891-1150 | ||
024 | 7 |
_a10.3949/ccjm.73.4.382 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSalehi, Marzieh | |
245 | 0 | 0 |
_aNew therapies for type 2 diabetes based on glucagon-like peptide 1. _h[electronic resource] |
260 |
_bCleveland Clinic journal of medicine _cApr 2006 |
||
300 |
_a382-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xanalogs & derivatives |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
700 | 1 | _aD'Alessio, David A | |
773 | 0 |
_tCleveland Clinic journal of medicine _gvol. 73 _gno. 4 _gp. 382-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3949/ccjm.73.4.382 _zAvailable from publisher's website |
999 |
_c16215445 _d16215445 |